A monoclonal antibody against anti-mullerian hormone
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Ant i-m ullerian honoone (AMH) has been partially purified from incubat ion medium of calf fetal testes (P icard and Josso. 1981 ). It produces mililerian regression i n organ culture and contains one major radioactive protein, when testes have been incubated i n the presence of trit iated fucose. Identity between AMH and this l8Oel-led marker protein has been postulated, and, in consequence, the latter has been used to screen hybridom8s for anti-AMH activity. Splenocytes of a BALB/c mouse, injected with partially purified AMH, produced 297 hybridomss sfter fusion with myeloma cell s. Culture medium from 94 was tested . in a doubIe antibody precipitation test, for its capacity to bind the l80elled protein conta ined i n partially purified medium. Three IgG hybridom8s gave positive results and one was cloned and used to produce ascites i n BALB/c mice . Ascites IgG, used as first antibody in a doub Le antibody precip itation test, prec ipitated the labelled protein and removed anti-mijllerian activity from medium containing bioactive AMH . The monoclonal antibody alao blocked anti-mulle rian act ivity of ca l f fetal testicular t issue. i nd i ca t i ng that it is directed against the biologically active portion of the AMH molecule. Theae results prove the identity between AMH and its biochemical marker, and should greatly hasten t he iaolation and quantitative assay of the hormone. Cellular DNA from ]D normal and 19 hypopituitary subjects waa studied t o determine whether heri table HGH deficiency is due to a l t e r a t i on i n the HGH/HPL gene c l us t e r on human chromosome 17. Svbj ec t s included 5 with multiple pit uitary hormone deficiency. ] with bioinactive HGH, 8 with isolated HGH deficiency without a f f ec t ed siblings and 2 pairs of siblings with autoaomal recessive i s olated HGH deficiency. DNA fragment a cont ai ni ng HGH and HPL-related gene s equences were detected by Southern blot hybridization to a ]2P-labeled HPL cDNA probe. HGH and HPL genes exiat in multiple, non-allelic forms. They are not resolved in Eco RI digeata but csn be distinguiahed in Bam HI and Bgl II digesta. We have detected ] variant polymorphic Bgl II restriction patterna whi ch are tra ceable through pedigrees and can be uaed to test for physical linkage of HGH deficiency to HGH/HPL gene c l us t e r variation . All HGH/HPL restriction patterns found in hypopituitary individuals were also found in normals . Thus, there were no instancea in which HGH deficiency coul d be attributed to deletion of an HGH gene. Also, discordance for Bgl II restriction patterns in 2 siblings with a ut os omal recessive HGH deficiency provided evidence against HGH gene mutation as the ca us e of the disease.
38
F.J.HOLLAND. D.DiBATTISTA* and L.LUNA* Hospital for Sick Children, U of 1bronto,Canada Somatomedin in the rhesus monkey fe tus To assess the role of somatomedin 1n the maturing fetus, a RIA was developed for Multiplication Stimulating Activity (MSA), a major somatomedin. Purified MSA was conjugated to hemocyanin and specific antiserum induced in rabbits. In the RIA there wae parallel displacement with unlabelled MSA and acid-extracted huaan or rhesus .ankey serum. There was no cross-reactivity with physiological concentrations of insulin or with the other somatomedina. Iamunoreactive MSA(I-MSA) in acromegalic serum extracts was approximately twice that of normal controls. while levels were reduced in growth hormone (GB) deficiency. I-MSA in pooled extracts from sera of 5 adult male monkeys was 84.0 ng/ml. Fetal samples were obtained from rhesus monkeys through catheterized interplacental vessels. At 90 days gestation (term 165 daya). I-KSA in 5 fetuses was 70.2 + 21 .0 ng/ml (mean + SEM). and at 160 days. 172.0 + 34.3 ng/ml-(P <0 .05).Correspo~ding GH levels were 50 .7 + 2.0~g/ml and 24.3 + 2 .3 ng/ml (P< O.OOl)(reported 6lat. End. Soc. 1979. Abat. 601) .-Beca us e of ID8rked variability, the mean level of I-MSA 1n day-old neonatea was not significantly different from fetal values. The riaing levels of I-MSA during the latter half of gestation in these studies suggest that:(l)somatomedins may plsy an important role in fetal growth; (2) so..tomedin may exert feedback inhibition on GH secretion during this period. Ontogen esis of soma t ogeni c a nd la ctog enic liver receptors in male and f"""' l e r at s.
To study t he regu l a tion of the l i ver somatogen ic IGHI and lact ogeni c IPRL) r ec ep t ors during dev el opmen t . t hei r number and affinit y we r e de termi ned at wee kl y interval s 1n male and female ratsJ the res ult s wer e corr el at ed wi t h gr owt h ve l oc i t y a nd the hormona l chan ge s in duced by puberty . The GH a nd PRL binding s i t es of l i ver homagBn~te 5 were anal yze d us i ng 12SI -bovl ne a nd 125I-ovlne PRL.
I n th e mal es. t he PRL recept ors were pr es ent a t day 21 [2 .D±D .5 pmoles /l iver , mea n±1 S. E. , n=51. reached a pea k at da y 35 (9±2, n-5 1. then dec reased to be undet ectab le at day 63 . In th e f """' l es . the i r evo lut i on was s imi la r unti l da y 35, thereaft er . a fo ur-fold i nc rea se occ urred. a pl atea u being reached at da y 49 [52±B, n-5 ) .
The numbe r o f GH rec ept or s e xh i b i t ed a progress i ve increase 1n mal es [day 21: 9±1, n=5, day 120 : 47±9. n-5 ) a nd females [day 21: 5±1. n=5, da y 120: 73±1D. n=5) . At t he time of pUbertal growth spurt t he mean number of GH receptors was equa l to 50% of the adult valu es . The aff i ni t y [Ka ) of GH and PRL r eceptors s howed no signi fica nt chan ge with age and se x fbGH: O.61tO . 03x1D 9 M-1, oPRL: D.9 3± D.D6x10 9 M -1 ,n-6D). These data suggest that in the male. t he pUbertal ri s e of t est os t er one inhib i ts the PRL recept ors. while i n the fema l e t he surge of estradiol i nduce s e sha r p increase of these rec ep to rs . The GH receptors do not app ear to be reguleted by gonadal steroIds.
M. COURMELEN, Y. LEBOUC, F. CIRARD and M. BINOUX Lab. explorations fonctionnelles and lNSERM U 142, HOpital Trousseau, 75012 Paris, France. rGF (i ns ul i n -l i k e growth factor ) levels i n cases of i di opa thi c t all stature. Serum leF levels were assayed. after acid extraction, in 26 girls and 32 boys (aged 1 -22) whose height for their age exceed] SO, by a radioligand assay using human IeF (gift from Dr Zapf, ZUrich) and a specific binding protein produced by rat liver in culture. Results are expressed in relation to a pool of normal adult serum arbitrarily assigned a value of 1 U/ml. 1) For the 15 children aged 1-10, the mean IeF level was 0.83~0.09 (SEH) U/ml which is significantly higher than that for normal children (0.59 C 0.05, n = 29) (p <0.01). 2) In the 21 10-15 year-old, IeF levels (1.35 ! 0.09) were higher than controls (1.05~0 .08, n =18) (p< 0.01). 7 girls and 1 boy had levels (1.52 -2.46) comparable to those of untreated acromegalics. CH levels 60 min after glucose load (30 g/m 2) were < 5 ng/ml in 11 subjects studied. 3) In the 22 patients over 15. leF levels (1.09 t 0.07) were similar to those of normal adults (1.06 : 0 .03 U/ml). 4) In 10 girls undere~nyloestradiol (200-300 fg/daf or a prognosis af a final height exceedIng 180 em, parallel with the decrease in growth, there was a slow but progressive drop in leF levels (means: 1.49 U/mi after] months, 1.08 after 1 year). The abnormally high IeF levels seen with idiopathic tall stature and the drop accompanying oestrogen therapy suggest a direct relation between leF production and growth rate. The return to normal levels once ossification is complete suggests a regulatory disorder durinQ the growth period.
